Trade KRSA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Korsana Biosciences, Inc. (KRSA) is trading at US$30.72, up 0.75% today as of Oct 5, 16:00 EDT. The company has a market capitalisation of US$1.98M. Over the past 52 weeks, KRSA has traded between US$21.00 and US$37.27. On Syfe you can trade KRSA with $0 commission and add it to your watchlist.
| Previous close | US$30.49 |
|---|---|
| Market cap | US$1.98M |
| 52-week range | US$21.00 – US$37.27 |
| Volume | 104.25K |
| Exchange | US |
Korsana Biosciences, Inc.
Korsana Biosciences, Inc. is a biopharmaceutical company, which engages in discovering and developing novel therapies to reduce the burden of neurodegenerative diseases. Its portfolio includes the KRSA-028 pipeline. The company was founded in 2024 and is headquartered in Waltham, MA.
Korsana Biosciences, Inc. (KRSA) stock is trading at US$30.72, +0.75% from the previous close of US$30.49.
The market cap for Korsana Biosciences, Inc. (KRSA) stock is approximately US$1.98M.
The 52-week high for Korsana Biosciences, Inc. (KRSA) stock is US$37.27.
The 52-week low for Korsana Biosciences, Inc. (KRSA) stock is US$21.00.
Korsana Biosciences, Inc. (KRSA) does not currently pay a dividend.
Stay on top of KRSA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
